MediDeferm
The computed 12-month bankruptcy probability of MediDeferm is 0.1% (very low). The 2025 annual accounts show equity of €210k and a net result of €216k. Its solvency ranks better than 65% of 2206 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €210k |
| Net result | €216k |
| Better than sector | 65% |
| Active | 1 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 74.8% | 58.1% | |
| Net result | €216k | €60k | |
| Equity | €210k | €74k | |
| Gross operating margin | €285k | €96k | |
| Total assets | €280k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €285k |
| Net profit | €216k |
| Cash flow | €218k |
| Staff costs | - |
| Income taxes | €67k |
| Dividends | - |
| Total assets | €280k |
| Equity | €210k |
| Debt | €71k |
| of which ≤ 1y | €71k |
| of which > 1y | - |
| Working capital | €203k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 3.88 |
| Quick ratio | 3.88 |
| Working capital ratio | 72.4% |
| Solvency | 74.8% |
| Debt / equity | 0.34 |
| Long-term debt ratio | - |
| Interest coverage | 4065.37 |
| Gross margin | - |
| Net margin | - |
| ROA | 77.2% |
| ROE | 103.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €280k |
| Fixed assets | 21/28 | €7k |
| Tangible fixed assets | 22/27 | €7k |
| Current assets | 29/58 | €274k |
| Amounts receivable within one year | 40/41 | €54k |
| Cash & bank | 54/58 | €220k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €280k |
| Equity | 10/15 | €210k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €207k |
| Amounts payable | 17/49 | €71k |
| Amounts payable within one year | 42/48 | €71k |
| Trade debts payable within one year | 44 | €1k |
| Income statement | ||
| Gross operating margin | 9900 | €285k |
| Operating result | 9901 | €283k |
| Financial charges | 65 | €70 |
| Result before taxes | 9903 | €283k |
| Income taxes | 67/77 | €67k |
| Net result for the period | 9904 | €216k |
| Result to be appropriated | 9905 | €216k |
-
Current01-07-2026 → present
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 09-08-2024 |
| Status | Active |
| Postal code | 3130 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24010C0048/00S000 | Flanders | 534 m² | 1 · 155 m² | 9.4 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
15-07-2026 General meeting · Officer appointment · Filing representative
- Publication: 15/07/2026 · MediDeferm
- Filing: 13-07-2026 · MediDeferm
- General meeting: 1 juli 2026 · MediDeferm
- Officer appointment: role: bestuurder, start_date: 2026-07-01 · Astrid Janssens
- Filing representative: lasthebber · Verschueren Randy
Technical details
{
"facts": [
{
"date": "2026-07-15",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 15/07/2026",
"value": "15/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-13",
"type": "filing",
"quote": "Neergelegd 13-07-2026",
"value": "13-07-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "general_meeting",
"quote": "Bijzondere algemene vergadering van 1 juli 2026",
"value": "1 juli 2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "officer_appointment",
"quote": "Benoeming: Astrid Janssens, bestuurder, ... met ingang van 1 juli 2026.",
"value": {
"role": "bestuurder",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"start_date": "1 juli 2026"
}
},
{
"type": "filing_representative",
"quote": "Ingediend door Verschueren Randy, lasthebber.",
"value": "lasthebber",
"object": "e1",
"subject": "e3"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1030,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "1012.361.086",
"kind": "company",
"name": "MediDeferm",
"attrs": {
"seat": "Werchtersesteenweg 58, 3130 Begijnendijk, Belgi\u00EB",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Astrid Janssens",
"attrs": {
"address": "Werchtersesteenweg 58, 3130 Begijnendijk"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Verschueren Randy",
"attrs": {}
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | MediDeferm |